Cargando…

Tumor progression locus 2 (TPL2) in tumor-promoting Inflammation, Tumorigenesis and Tumor Immunity

Over the years, tumor progression locus 2 (TPL2) has been identified as an essential modulator of immune responses that conveys inflammatory signals to downstream effectors, subsequently modulating the generation and function of inflammatory cells. TPL2 is also differentially expressed and activated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Njunge, Lucy Wanjiru, Estania, Andreanne Poppy, Guo, Yao, Liu, Wanqian, Yang, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381748/ https://www.ncbi.nlm.nih.gov/pubmed/32724474 http://dx.doi.org/10.7150/thno.45848

Ejemplares similares

Tumor Progression Locus 2 (TPL2) Regulates Obesity-Associated Inflammation and Insulin Resistance
por: Perfield, James W., et al.
Publicado: (2011)

Tumor Progression Locus 2 (Tpl2) Kinase as a Novel Therapeutic Target for Cancer: Double-Sided Effects of Tpl2 on Cancer
por: Lee, Hye Won, et al.
Publicado: (2015)

Tumor Progression Locus 2 (Tpl2) Deficiency Does Not Protect against Obesity-Induced Metabolic Disease
por: Lancaster, Graeme I., et al.
Publicado: (2012)

Serine Metabolic Reprogramming in Tumorigenesis, Tumor Immunity, and Clinical Treatment
por: Shunxi, Wang, et al.
Publicado: (2023)

Tumor-Associated Inflammation: The Tumor-Promoting Immunity in the Early Stages of Tumorigenesis
por: Bi, Qing, et al.
Publicado: (2022)

Altered Prostanoid Signaling Contributes to Increased Skin Tumorigenesis in Tpl2 Knockout Mice
por: DeCicco-Skinner, Kathleen L., et al.
Publicado: (2013)

IKBKE-driven TPL2 and MEK1 phosphorylations sustain constitutive ERK1/2 activation in tumor cells
por: Göktuna, Serkan Ismail
Publicado: (2022)

Role of DKK4 in Tumorigenesis and Tumor Progression
por: Cai, Xinjia, et al.
Publicado: (2018)

TPL-2 restricts Ccl24-dependent immunity to Heligmosomoides polygyrus
por: Kannan, Yashaswini, et al.
Publicado: (2017)

TPL2/COT/MAP3K8 (TPL2) Activation Promotes Androgen Depletion-Independent (ADI) Prostate Cancer Growth
por: Jeong, Joseph H., et al.
Publicado: (2011)

Foot-and-Mouth Disease Virus Structural Protein VP1 Destroys the Stability of the TPL2 Trimer by Degradation of TPL2 To Evade Host Antiviral Immunity
por: Zhang, Keshan, et al.
Publicado: (2021)

Inflammation, immune suppression, and tumor progression
por: Ostrand-Rosenberg, Suzanne
Publicado: (2013)

Inhibition of HGF/MET signaling decreases overall tumor burden and blocks malignant conversion in Tpl2-related skin cancer
por: Bonan, Nicole F., et al.
Publicado: (2019)

Tumor progression locus 2 ablation suppressed hepatocellular carcinoma development by inhibiting hepatic inflammation and steatosis in mice
por: Li, Xinli, et al.
Publicado: (2015)

The Role of Inhaled Anesthetics in Tumorigenesis and Tumor Immunity
por: Xu, Yichi, et al.
Publicado: (2020)

TPL2 kinase expression is regulated by the p38γ/p38δ-dependent association of aconitase-1 with TPL2 mRNA
por: Escós, Alejandra, et al.
Publicado: (2022)

The role of galectin-3 in the tumorigenesis and progression of pituitary tumors
por: Diao, Bo, et al.
Publicado: (2018)

The Role of DACT Family Members in Tumorigenesis and Tumor Progression
por: Zeng, Yu, et al.
Publicado: (2022)

Tumor progression locus 2 reduces severe allergic airway inflammation by inhibiting Ccl24 production in dendritic cells
por: Kannan, Yashaswini, et al.
Publicado: (2017)

TPL‐2 kinase induces phagosome acidification to promote macrophage killing of bacteria
por: Breyer, Felix, et al.
Publicado: (2021)

Expression of the Tpl2/Cot oncogene in human T-cell neoplasias
por: Christoforidou, Anna V, et al.
Publicado: (2004)

TPL2 mediates IL-17R signaling in neuroinflammation
por: Xiao, Yichuan, et al.
Publicado: (2015)

TPL2 mediates autoimmune inflammation through activation of the TAK1 axis of IL-17 signaling
por: Xiao, Yichuan, et al.
Publicado: (2014)

Necroptosis in tumorigenesis, activation of anti-tumor immunity, and cancer therapy
por: Meng, Mao-Bin, et al.
Publicado: (2016)

Prostaglandin E2 and Receptors: Insight Into Tumorigenesis, Tumor Progression, and Treatment of Hepatocellular Carcinoma
por: Chen, Chao, et al.
Publicado: (2022)

The role of ALDH2 in tumorigenesis and tumor progression: Targeting ALDH2 as a potential cancer treatment
por: Zhang, Hong, et al.
Publicado: (2021)

TPL2-NPM-p53 pathway monitors nucleolar stress
por: Eliopoulos, Aristides G., et al.
Publicado: (2015)

Role of tumor microenvironment in tumorigenesis
por: Wang, Maonan, et al.
Publicado: (2017)

Necroptosis, tumor necrosis and tumorigenesis
por: Liu, Zheng-gang, et al.
Publicado: (2019)

Monocytes in Tumorigenesis and Tumor Immunotherapy
por: Chen, Xiaodie, et al.
Publicado: (2023)

DDX5 and DDX17—multifaceted proteins in the regulation of tumorigenesis and tumor progression
por: Xu, Kun, et al.
Publicado: (2022)

NF-κB1 p105 suppresses lung tumorigenesis through the Tpl2 kinase but independently of its NF-κB function
por: Sun, Fan, et al.
Publicado: (2015)

Tamiz de problemas del lenguaje-TPL
por: Auza Benavides, Alejandra

Gain-of-Function Mutations in the Toll-Like Receptor Pathway: TPL2-Mediated ERK1/ERK2 MAPK Activation, a Path to Tumorigenesis in Lymphoid Neoplasms?
por: Rousseau, Simon, et al.
Publicado: (2016)

Role of DUSP1/MKP1 in tumorigenesis, tumor progression and therapy
por: Shen, Jiliang, et al.
Publicado: (2016)

Understanding the Dual Roles of CircHIPK3 in Tumorigenesis and Tumor Progression
por: Wei, Zeyu, et al.
Publicado: (2022)

TPL2 kinase activity regulates microglial inflammatory responses and promotes neurodegeneration in tauopathy mice
por: Wang, Yuanyuan, et al.
Publicado: (2023)

Cyclooxygenase-2 promotes tumor growth and suppresses tumor immunity
por: Liu, Bing, et al.
Publicado: (2015)

Two TPL-Binding Motifs of ARF2 Are Involved in Repression of Auxin Responses
por: Choi, Hee-Seung, et al.
Publicado: (2018)

Corrigendum: DDX5 and DDX17—multifaceted proteins in the regulation of tumorigenesis and tumor progression
por: Xu, Kun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_720716ksunv0a427smtplh0e5j